Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

6.3%

1 terminated out of 16 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results80% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (6)
P 1 (2)
P 2 (2)

Trial Status

Unknown7
Completed4
Recruiting2
Terminated1
Active Not Recruiting1
Not Yet Recruiting1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT05286814Phase 2Recruiting

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

NCT07558304Not ApplicableNot Yet Recruiting

Suprapapillary Metal Stent vs. Routine Transpapillary Drainage in Malignant Hilar Biliary Obstruction (SMART-B Trial)

NCT00582647Active Not Recruiting

Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract

NCT01232101Not ApplicableCompletedPrimary

Covered or Uncovered Bile Duct Stents

NCT05600803Unknown

Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions

NCT06115655UnknownPrimary

A Single-center, Prospective Cohort Study on the Differentiation of Benign and Malignant Bile Duct Stenosis Based on Bile and Peripheral Blood cfDNA Methylation Profiles

NCT04276090Not ApplicableTerminatedPrimary

Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma

NCT01845337Phase 2Completed

Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine

NCT05374122Not ApplicableUnknown

AI Guidance for Biopsy in Suspected Cholangiocarcinoma

NCT05320328UnknownPrimary

RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY OBSTRUCTION

NCT04847167Not ApplicableCompleted

Mechanistic Loop Resolution Strategy for Short-type Single Balloon Enteroscopy

NCT05172310Phase 1Recruiting

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

NCT00634751Phase 1Completed

CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma

NCT03951324Unknown

Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study

NCT03838913UnknownPrimary

Whole-Exome Sequencing (WES) of Intraductal Neoplasms of the Bile Duct (IPNB)

NCT00915863Not ApplicableUnknown

Evaluation of Isolated Roux-en-Y Reconstruction After Pancreaticoduodenectomy

Showing all 16 trials

Research Network

Activity Timeline